MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 12-16-2023
Covetrus Cash and Cash Equivalents 2011-2026 | CVET
Annual Cash and Cash Equivalents Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 183 M | 290 M | 130 M | 23 M | 16 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 290 M | 16 M | 128 M |
Quarterly Cash and Cash Equivalents Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 117 M | 183 M | 187 M | 230 M | 211 M | 290 M | 290 M | 290 M | 290 M | 130 M | 130 M | 130 M | 130 M | 23 M | 23 M | 23 M | 23 M | 16 M | - | - | - | 19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 290 M | 16 M | 144 M |
Cash and Cash Equivalents of other stocks in the Health information services industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
182 M | $ 5.64 | 3.3 % | $ 90.5 M |  USA |
 |
Accolade
ACCD
|
434 M | - | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
616 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
3.85 M | - | 4.4 % | $ 133 M | USA |
 |
iCAD
ICAD
|
17.2 M | - | - | $ 102 M | USA |
 |
1Life Healthcare
ONEM
|
342 M | - | - | $ 3.37 B | USA |
 |
Omnicell
OMCL
|
369 M | $ 41.91 | 0.9 % | $ 1.93 B | USA |
 |
Akerna Corp.
KERN
|
735 K | - | - | $ 161 M | USA |
 |
HealthStream
HSTM
|
59.5 M | $ 21.98 | -0.34 % | $ 668 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
188 M | - | -10.39 % | $ 886 M | USA |
 |
Evolent Health
EVH
|
188 M | $ 3.3 | -7.18 % | $ 309 M | USA |
 |
HealthEquity
HQY
|
404 M | $ 80.18 | -1.21 % | $ 6.86 B | USA |
 |
MTBC
MTBC
|
5.14 M | - | -0.58 % | $ 51.7 M | USA |
 |
Change Healthcare
CHNG
|
113 M | - | - | $ 9.03 B | USA |
 |
So-Young International
SY
|
1.13 B | $ 2.93 | 1.74 % | $ 233 M |  China |
 |
10x Genomics
TXG
|
359 M | $ 22.07 | -1.34 % | $ 2.59 B | USA |
 |
Veeva Systems
VEEV
|
703 M | $ 192.75 | 2.4 % | $ 30.9 B | USA |
 |
GoodRx Holdings
GDRX
|
448 M | $ 2.29 | 4.82 % | $ 883 M | USA |
 |
Health Catalyst
HCAT
|
250 M | $ 1.87 | -4.36 % | $ 113 M | USA |
 |
Progyny
PGNY
|
162 M | $ 17.43 | -2.02 % | $ 1.5 B | USA |
 |
Premier
PINC
|
83.7 M | - | - | $ 2.33 B | USA |
 |
Teladoc Health
TDOC
|
781 M | $ 5.07 | -1.27 % | $ 893 M | USA |
 |
R1 RCM
RCM
|
130 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
1.76 M | - | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
13.9 M | $ 7.53 | -4.32 % | $ 129 M | USA |
 |
NextGen Healthcare
NXGN
|
73.3 M | - | - | $ 1.6 B | USA |
 |
Phreesia
PHR
|
87.5 M | $ 12.17 | -3.64 % | $ 664 M | USA |
 |
SCWorx Corp.
WORX
|
107 K | $ 0.13 | -6.25 % | $ 190 K | USA |
 |
Schrödinger
SDGR
|
231 M | $ 12.8 | -2.44 % | $ 940 M | USA |
 |
Zhongchao
ZCMD
|
15.1 M | $ 1.67 | 0.04 % | $ 8.69 M | China |
 |
Signify Health
SGFY
|
466 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
2.18 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
70 M | - | - | $ 255 M | USA |